prof. dr. E. (Eelko) Hak

Hoogleraar Farmacoepidemiologie / Hoofd afdeling FarmacoTherapie, -Epidemiologie, -Economie

Faculteit Science and Engineering

Telefoon:

06 5001 9923 (Secretariaat)

050 36 32772 (fax)

E-mail:

e.hak rug.nl

Homepage ORCID Research Portal

Publicaties

Novel observational study designs with new influenza vaccines

Hak, E., mrt.-2015, In: Lancet Infectious Diseases. 15, 3, blz. 253-254 2 blz.

Onderzoeksoutput › › peer review

Birth cohort appeared to confound effect estimates of guideline changes on statin utilization

Bijlsma, M. J., Janssen, F., Lub, R., Bos, J. H. J., De Vries, F. M., Vansteelandt, S. & Hak, E., mrt.-2015, In: Journal of Clinical Epidemiology. 68, 3, blz. 334-340 7 blz.

Onderzoeksoutput › › peer review

Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?

Pouwels, K. B., Kalkman, G. A., Schagen, D., Visser, S. T. & Hak, E., jul.-2014, In: British Journal of Clinical Pharmacology. 78, 1, blz. 192-193 2 blz.

Onderzoeksoutput › › peer review

Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies

Darvishian, M., Bijlsma, M. J., Hak, E. & van den Heuvel, E. R., dec.-2014, In: Lancet Infectious Diseases. 14, 12, blz. 1228-1239 12 blz.

Onderzoeksoutput › › peer review

Antibiotic use among dutch pregnant woman and the development of toddler asthma: The influence of confounding

Mulder, B., Pouwels, K. B., Schuiling-Veninga, N. C. M., Bos, J., De Vries, T. W., Jick, S. S. & Hak, E., okt.-2014, In: Pharmacoepidemiology and Drug Safety. 23, S1, blz. 20-21 2 blz.

Onderzoeksoutput ›

After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly

Darvishian, M., Gefenaite, G., Turner, R. M., Pechlivanoglou, P., Van der Hoek, W., Van den Heuvel, E. R. & Hak, E., jul.-2014, In: Journal of Clinical Epidemiology. 67, 7, blz. 734-744 11 blz.

Onderzoeksoutput › peer review

A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease

Alghamdi, A., Vos ,de, S., Bos, J., Schuiling-Veninga, C., van Munster, B. C., Mubarik, S., Luijendijk, H. J. & Hak, E., feb.-2025, In: Journal of Alzheimer's disease : JAD. 103, 3, blz. 706-713 8 blz.

Onderzoeksoutput › › peer review

A pharmacological view on accounting for pharmacokinetic factors in the estimation of pharmaceutical emissions based on drug usage data: Comment on: Zillien C et al., Assessing city-wide pharmaceutical emissions to wastewater via modelling and passive sampling, Envir Int. vol. 185, March 2024, 108524

Klont, F., Bellinga, J. S., Giunchi, V., Balafas, S. & Hak, E., feb.-2025, In: Environment international. 196, 3 blz., 109312.

Onderzoeksoutput › › peer review

Correction to: Comparison of antipsychotic drug use in children and adolescents in the Netherlands before and during the COVID-19 pandemic

Gangapersad, R. N., Zhou, G., Garcia-Gomez, P., Bos, J., Hak, E., Koch, B. C. P., Schuiling-Veninga, C. C. M. & Dierckx, B., jan.-2025, In: European Child & Adolescent Psychiatry. 34, 1, blz. 375

Onderzoeksoutput

Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults in the Netherlands: A Retrospective Inception Cohort Study

Zhou, G., Mommers, I., Schuiling-Veninga, C., Bos, J., Rengerink, K. O., Pasmooij, A., Mol, P., van Baarle, D., de Bock, G., van Boven, J. & Hak, E., 9-apr.-2025, In: Clinical epidemiology. 17, blz. 337—352 16 blz.

Onderzoeksoutput › › peer review